GGrantIndex
← Search

CHEMOPREVENTIVE TARGETING OF THE PROSTATE CANCER-INITIATING CELL BY PROSENESCENCE THERAPY

$124,200FY2010Department of the ArmyDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators

View source on USAspending →
CHEMOPREVENTIVE TARGETING OF THE PROSTATE CANCER-INITIATING CELL BY PROSENESCENCE THERAPY · GrantIndex